310 related articles for article (PubMed ID: 19481526)
1. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.
Hutti JE; Shen RR; Abbott DW; Zhou AY; Sprott KM; Asara JM; Hahn WC; Cantley LC
Mol Cell; 2009 May; 34(4):461-72. PubMed ID: 19481526
[TBL] [Abstract][Full Text] [Related]
2. IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation.
Shen RR; Zhou AY; Kim E; Lim E; Habelhah H; Hahn WC
Mol Cell Biol; 2012 Dec; 32(23):4756-68. PubMed ID: 23007157
[TBL] [Abstract][Full Text] [Related]
3. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.
Zhang M; Wu X; Lee AJ; Jin W; Chang M; Wright A; Imaizumi T; Sun SC
J Biol Chem; 2008 Jul; 283(27):18621-6. PubMed ID: 18467330
[TBL] [Abstract][Full Text] [Related]
4. IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.
Zhou AY; Shen RR; Kim E; Lock YJ; Xu M; Chen ZJ; Hahn WC
Cell Rep; 2013 Mar; 3(3):724-33. PubMed ID: 23453969
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
Reiley W; Zhang M; Wu X; Granger E; Sun SC
Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
[TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
[TBL] [Abstract][Full Text] [Related]
7. IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.
Guo JP; Shu SK; Esposito NN; Coppola D; Koomen JM; Cheng JQ
J Biol Chem; 2010 Feb; 285(6):3676-3684. PubMed ID: 19940156
[TBL] [Abstract][Full Text] [Related]
8. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
9. Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation.
Gringhuis SI; Kaptein TM; Wevers BA; Mesman AW; Geijtenbeek TB
Nat Commun; 2014 May; 5():3898. PubMed ID: 24867235
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of estrogen receptor α-36 by breast cancer oncogene IKKε promotes growth of ER-negative breast cancer cells.
Li Q; Sun H; Zou J; Ge C; Yu K; Cao Y; Hong Q
Cell Physiol Biochem; 2013; 31(6):833-41. PubMed ID: 23816933
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
Kobayashi T; Masoumi KC; Massoumi R
Oncogene; 2015 Apr; 34(17):2251-60. PubMed ID: 24909169
[TBL] [Abstract][Full Text] [Related]
12. [The IKKε kinase in breast cancer: from oncogenesis to treatment resistance].
Grandvaux N
Med Sci (Paris); 2011; 27(6-7):619-25. PubMed ID: 21718646
[TBL] [Abstract][Full Text] [Related]
13. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
Eddy SF; Guo S; Demicco EG; Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2005 Dec; 65(24):11375-83. PubMed ID: 16357145
[TBL] [Abstract][Full Text] [Related]
14. Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.
Qin B; Cheng K
Breast Cancer Res; 2010; 12(5):R74. PubMed ID: 20863366
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death.
Renner F; Moreno R; Schmitz ML
Mol Cell; 2010 Feb; 37(4):503-15. PubMed ID: 20188669
[TBL] [Abstract][Full Text] [Related]
16. Importance of Validating Antibodies and Small Compound Inhibitors Using Genetic Knockout Studies-T Cell Receptor-Induced CYLD Phosphorylation by IKKε/TBK1 as a Case Study.
Lork M; Kreike M; Staal J; Beyaert R
Front Cell Dev Biol; 2018; 6():40. PubMed ID: 29755980
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Tumor Suppressor CYLD Sensitizes Mice to Breast Cancer Development.
Pseftogas A; Xanthopoulos K; Siasiaridis A; Poutahidis T; Gonidas C; Tsingotjidou A; Hatzivassiliou E; Mosialos G
Anticancer Res; 2024 May; 44(5):1885-1894. PubMed ID: 38677721
[TBL] [Abstract][Full Text] [Related]
18. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.
Iliopoulos D; Jaeger SA; Hirsch HA; Bulyk ML; Struhl K
Mol Cell; 2010 Aug; 39(4):493-506. PubMed ID: 20797623
[TBL] [Abstract][Full Text] [Related]
19. Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses.
DeDiego ML; Martinez-Sobrido L; Topham DJ
J Virol; 2019 Nov; 93(21):. PubMed ID: 31434731
[TBL] [Abstract][Full Text] [Related]
20. Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon.
Harris J; Olière S; Sharma S; Sun Q; Lin R; Hiscott J; Grandvaux N
J Immunol; 2006 Aug; 177(4):2527-35. PubMed ID: 16888014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
